Osteoporosis International

Article	Citations
A promising strategy for the diagnosis, treatment, and prevention of osteoporosis (EMS strategy)	183
Correction to: Author response to the comments on our article Relatively low and moderate pre-fracture serum 25-hydroxyvitamin D levels associated with the highest survival in elderly hip fracture pat	178
RETRACTED ARTICLE: Evaluation of bone mineral density (BMD) and trabecular bone score (TBS) in pheochromocytoma and paraganglioma; a multi-centric case–control study from India	134
The clinical trial landscape of anti-RANKL agents for osteoporosis: current status and future directions	103
Successful treatment using asfotase alfa for delayed healing of a metatarsal stress fracture in an adolescent girl with hypophosphatasia	96
Post-fracture care and predictors of anti-osteoporotic treatment in Switzerland: a nationwide health claims analysis	81
Epidemiology of pelvic and acetabular fractures in the USA from 2007 to 2014	79
The incidence of subsequent contralateral hip fracture and factors associated with increased risk: the IMPACT Contralateral Fracture Study	79
Comparison of the efficacy between sequential therapy with teriparatide and denosumab and denosumab monotherapy in suppressing fragility fracture risk	78
Postmenopausal osteoporosis and the global burden of fractures: a gynecologist’s perspective	67
Association between SGLT2 inhibitor use and the risk of vertebral augmentation after initial osteoporotic vertebral fracture in patients with type 2 diabetes	67
Scaffolds: a biomaterial engineering in targeted drug delivery for osteoporosis	56
The effects of β-carotene on osteoporosis: a systematic review and meta-analysis of observational studies	54
Authors’ reply to comment on: Effect of protein supplementation on hip bone mineral density, cortical thickness, and bone strength in older adult participants during a caloric restriction and aerobic	52
Authors’ reply to 2nd comment on: effect of protein supplementation on hip bone mineral density, cortical thickness, and bone strength in older adult participants during a caloric restriction and aero	50
Trajectories of oral bisphosphonate use after hip fractures: a population-based cohort study	50
Bone mineral density assessment using radiofrequency echographic multispectrometry (REMS) in patients before and after total hip replacement	45
Follicle-stimulating hormone is associated with low bone mass in postmenopausal women	45
The link between osteoporosis and cardiovascular diseases: a review of shared mechanisms, risk factors, and therapeutic approaches	44
Changes in spinal sagittal balance after a new osteoporotic vertebral compression fracture	43
Return on investment of fracture liaison services: a systematic review and analysis	40
The association between blood cadmium levels and bone mineral density in U.S. adolescents aged 12–19 years	39
One versus 2 years of alendronate following denosumab: the CARD extension	38
Impact of the guidance on fracture Liaison Services and the introduction of a new fee for secondary fracture prevention in Japan: Implementation of secondary fracture prevention during hospitalization	37
Association between dental diseases and oral hygiene care and the risk of vertebral fracture: a nationwide cohort study	37

Atypical femoral fracture after denosumab for the treatment of osteoporosis in bisphosphonate naïve patients: two further cases	37
A summary of the Russian clinical guidelines on the diagnosis and treatment of osteoporosis	36
Artificial intelligence insights into osteoporosis: comment	36
Author response to: Comment from Dongdong Cao, et al. on: Rapid reduction in fracture risk after the discontinuation of long-term oral glucocorticoid therapy: a retrospective cohort study using a nati	36
Comparison of radiological and functional outcomes of conservative treatment with teriparatide and denosumab in thoracolumbar osteoporotic vertebral fracture	35
International consensus on the non-pharmacological and non-surgical management of osteoporotic vertebral fractures	35
Advantages of measuring hand grip strength in osteoporosis patients	34
Alendronate preserves bone mineral density in adults with sickle cell disease and osteoporosis	33
Incidence of proximal humerus fracture among older adults in Oslo, Norway varies by country background, marital status, and season	31
Treatment patterns of romosozumab in postmenopausal women with severe osteoporosis in Denmark: findings from the ROmosozumab in Scandinavia real-world Evidence Study (ROSES)	31
Latent metabolic bone disease, skeletal dysplasia and other conditions related to low bone formation among 38 patients with subtrochanteric femoral fractures: a retrospective observational study	31
Comparison of pharmacokinetics, pharmacodynamics, safety, and immunogenicity of teriparatide biosimilar with EU- and US-approved teriparatide reference products in healthy men and postmenopausal women	30
Bisphosphonate drug holidays in osteoporosis according to fracture risk profile	30
Adjusting conventional FRAX estimates of fracture probability according to the number of prior falls in the preceding year	29
Projected burden of femoral fracture surgeries in Japan through 2035: a nationwide population-based modeling study	29
“Build better bones”: development, launch, and future directions of a multilingual, user-centered website for osteoporosis management	29
Differential fracture risk in breast cancer patients based on endocrine therapy and age: a nationwide cohort study	29
Opportunistic measures of bone mineral density at multiple skeletal sites during whole-body CT in polytrauma patients	29
Association between vestibular dysfunction and osteoporosis in adults: a systematic review and meta-analysis	29
Letter of Rebuttal: Muscle mass, not fat mass, predicts vertebral fracture risk: Vietnam osteoporosis study	29
Evaluating the impact of COVID-19 on DXA waiting lists and osteoporosis prescription trends in England 2019–2023	29
Accelerometer-measured weekly and diurnal moderate-to-vigorous physical activity patterns and incident osteoporosis	28
Clinical and demographic factors determining patient fracture risk decision point (FRDP): The improving risk communication in osteoporosis (RICO) project	28
Bridging the knowledge gap in rare bone disorders: insights from the APCO Asia-Pacific Rare Bone Disorders Engagement (ASPIRE) survey	28
AI-derived bone mineral density from standard radiographs compared with DXA for fracture prediction in a 10-year real-world cohort study	28
Proposed bone health screening protocol to identify total knee arthroplasty patients for preoperative DXA	28
Trends of clinical vertebral and hip fractures following local government involvement in fracture prevention from 2015 to 2021 in Kure, Japan	27
Comparison of country-specific FRAX models throughout Latin America: lessons from Costa Rica and Ecuador	27
Comorbidity and risk of infection among patients with hip fracture: a Danish population-based cohort study	27
IOF REGIONAL 2025 9th Asia-Pacific Bone Health Conference: Sponsored Sessions Abstracts	27
The importance of structural barriers of osteoporotic hip fracture in the elderly	26
Author response to OSIN-D-23–00510, “Comment on: A multicenter retrospective study of the risk factors associated with medication-related osteonecrosis of the jaw after tooth extraction in patients re	26
Twenty-four months of follow-up in women with rebound-associated vertebral fractures after discontinuation of denosumab: a single-centre case series	26
A randomised Phase 3 study comparing the efficacy and safety of proposed denosumab biosimilar RGB-14-P and reference denosumab in women with postmenopausal osteoporosis	25
Correction: Optimum dose of vitamin D for disease prevention in older people: BEST-D trial of vitamin D in primary care	25
Temporal trends in socioeconomic inequalities and risk of infection after hip fracture surgery: a nationwide cohort study, 2010–2021	25
Fracture liaison service evaluation during admission for fragility femur fracture increases rates of bone health intervention and outpatient follow-up	25
Joint association of milk intake and blood 25(OH)D levels with fracture risk in postmenopausal women: 20-year follow-up data from the Japanese Population-Based Osteoporosis cohort study	25
Updated trabecular bone score accounting for the soft tissue thickness (TBSTT) demonstrated significantly improved bone microstructure with denosumab in the FREEDOM TBS post hoc analysis	25
Comment on: The association between myasthenia gravis and risk of fracture: a systematic review and meta-analysis	25
Trends of incidence and 1-year mortality of vertebral fractures in Korea	24
Comment on: A novel sequential treatment approach between denosumab and romosozumab in patients with severe osteoporosis	24
Correction: PTH1 receptor agonists for fracture risk: a systematic review and network meta-analysis	24
Letter to the editor	24
Correction to: Secular trends of incidence and hospitalization cost of hip fracture in Tangshan, China	24
Long-term effects of premenopausal risk-reducing salpingo-oophorectomy on bone mineral density	23
Zoledronic acid–induced severe lymphopenia	23
Characterizing types and circumstances of fractures in the Canadian Multicentre Osteoporosis Study	23
Comment on: Comparing home‑based and institutional rehabilitation for community‑dwelling hip fracture patients: a matched cohort study	23
Metformin treatment reduces the incidence of osteoporosis: a two-sample Mendelian randomized study	23

Causal relationship between type 2 diabetes mellitus and bone mineral density: a Mendelian randomization study in an East Asian population	23
A meta-analysis of smoking and fracture risk to update the FRAX® tool	23
The association between lumbar paraspinal muscle functional cross-sectional area on MRI and regional volumetric bone mineral density measured by quantitative computed tomography	22
Insulin resistance, bone health, and fracture risk	22
Semi-automatic proximal humeral trabecular bone density assessment tool: technique application and clinical validation	22
Denosumab and clinical outcomes among men with osteoporosis: a retrospective cohort study	22
Comment on: Abdalbary et al. Impact of urinary calcium excretion on kidney, bone, and cardiovascular systems in patients with bone biopsy proven osteoporosis: a longitudinal long-term follow-up study.	21
Authors’ response to 01460, renal dysfunction and its influence on osteoporosis treatment outcomes: a critical review of recent findings	21
Three months of abaloparatide treatment rapidly improves bone formation and density: implications for orthopedic preoperative bone health optimization	21
Opportunistic osteoporosis screening using chest CT with artificial intelligence	21
Author response to OSIN-D-24–00958 comment on: the association between myasthenia gravis and risk of fracture: a systematic review and meta-analysis	21
Effects of microplastics on the bones: a comprehensive review	21
Letter to the Editor regarding “Associations between ultra-distal forearm bone mineral density and incident fracture in women”	21
Letter of rebuttal to ‘Comment on: Imaging of pelvic ring fractures in older adults and its clinical implications—a systematic review’	21
Imaging of pelvic ring fractures in older adults and its clinical implications-a systematic review	21
Impact of the COVID-19 pandemic on osteoporotic hip fractures among outpatients in Germany	20
Error in Mendelian randomization analysis in “Higher risk of osteoporosis in adult-onset asthma than childhood-onset asthma”	20
Bone, cognitive, and anthropometric profiles and their relation to fracture sites in fallers: a cross-sectional study	20
A novel fracture liaison service using digital health: impact on mortality in hospitalized elderly osteoporotic fracture patients	19
Correction to: Denosumab-related osteonecrosis of the jaw after tooth extraction and the effects of a short drug holiday in cancer patients: a multicenter retrospective study	19
Anabolic-first therapy and planned sequential care in very-high-risk fracture patients: leveraging the REFRA FLS-SEIOMM signal for global implementation	19
Correction: determination of the combined effects of asian herbal medicine with calcium and/or vitamin D supplements on bone mineral density in primary osteoporosis: a systematic review and meta-analy	19
Prior fragility fractures are associated with a higher risk of 8-year complications following total shoulder arthroplasty	19
Comment on “Association of serum alkaline phosphatase levels with bone mineral density, osteoporosis prevalence, and mortality in US adults with osteoporosis: evidence from NHANES 2005–2018”	19
Correction to: Effect of institution volume on mortality and outcomes in osteoporotic hip fracture care	19
Standardization of the nomenclature of bone status indices: a milestone in diagnostic consistency and clarity	19
Mortality among older adults with osteoporotic vertebral fracture	18
Correction to: Determination of the combined effects of asian herbal medicine with calcium and/or vitamin D supplements on bone mineral density in primary osteoporosis: A systematic review and meta-an	18
Comparison of traditional and new treatments for fibrous dysplasia: a systematic review and meta-analysis	18
Development and validation of a prediction model for falls among older people using community-based data	18
Metabolic equivalents may obscure the skeletal risks of occupational physical activity	18
Effect of protein supplementation on hip bone mineral density, cortical thickness, and bone strength in older adult participants during a caloric restriction and aerobic exercise weight loss intervent	17
Osteoporotic vertebral fractures localized in the lumbar area significantly impact sagittal alignment	17
Key insights into antiresorptive drug use and osteonecrosis in osteoporotic patients undergoing tooth extractions: A clinical and CBCT assessment	17
Efficacy and safety of romosozumab in patients with chronic kidney disease and osteoporosis: a narrative review	17
Association between osteoporosis and risk of dementia: a Korean women nationwide population-based cohort study	17
A longitudinal genome-wide association study of bone mineral density mean and variability in the UK Biobank	16
A tribute to Uri A. Liberman, 1935–2022	16
Baseline serum PINP level is associated with the increase in hip bone mineral density seen with Romosozumab treatment in previously untreated women with osteoporosis	16
Dietary and supplemental calcium intake and bone changes during antiresorptive osteoporosis treatment in older women: a longitudinal observational study	16
Nrf2 signaling pathway: focus on oxidative stress in osteoporosis	16
Author Response to OSIN-D-24–00437: Letter to the Editor regarding “Associations between ultra-distal forearm bone mineral density and incident fracture in women”	16
A low serum alkaline phosphatase may signal hypophosphatasia in osteoporosis clinic patients	16
Race-specific FRAX models are evidence-based and support equitable care: a response to the ASBMR Task Force report on Clinical Algorithms for Fracture Risk	16
Prevalence of low bone mineral density (T-score ≤  − 2.5) in the whole spectrum of chronic kidney disease: a systematic review and meta-analysis	16
Bone mineral density and lipid profiles in older adults: a nationwide cross-sectional study	16
Costs of incident non-hip osteoporosis-related fractures in postmenopausal women from a payer perspective	16
Editorial: Is REMS-BMD Truly a Measured Parameter? A Call for Transparency and Technical Clarification	16
RE: Clinical features of fallers and non-fallers: Finding best-performing combinations of physical performance measurements to discriminate physical impairments between fallers and non-fallers among o	15
Parathyroid hormone and alkaline phosphatase are associated with fracture risk in non-dialysis-dependent chronic kidney disease	15
Acute immune-mediated hepatocellular injury temporally associated with romosozumab: a probable autoimmune-like drug-induced liver injury	15
Metabolic factors associated with incident fracture among older adults with type 2 diabetes mellitus: a nested case–control study	15
Delayed and significant hypercalcaemia due to teriparatide therapy: a case report and review	15
Comment on Byun et al.: The effect of teriparatide on fracture healing after atypical femoral fracture: a systematic review and meta-analysis	15
Skeletal health status among patients with chronic hypoparathyroidism: results from the Canadian National Hypoparathyroidism Registry (CNHR)	15
Letter to the editor concerning “Sex differences in hemoglobin levels and five-year refracture risk in patients with osteoporotic fractures: a retrospective cohort analysis”	15
Group-based trajectories of potentially preventable hospitalisations among older adults after a hip fracture	15
Author response to OSIN-D-26-00399 bone protection in breast cancer: durability and discontinuation	15
Mortality in patients over 65 with proximal humerus fractures: a systematic review of 414,379 shoulders with meta-analysis	15
Femur geometry influences atypical femoral fracture location	15
Milk intake and hip fracture incidence in community-dwelling old Icelandic adults	15
Opportunistic use of lumbar computed tomography and magnetic resonance imaging for osteoporosis screening	15
Fracture risks in patients aged 50 years and older with panhypopituitarism: a nationwide cohort study	14
Demographics and medical burden of osteogenesis imperfecta: a nationwide database analysis	14
Fragility fracture and fear of falling in middle aged adults-a prevalence study	14
Preventing post-denosumab bone loss with zoledronate: a 2-year randomized trial in post-menopausal women without and with pre-exposure to bisphosphonates	14
The hip fracture incidence in the high-risk area Oslo continues to decline	14
Letter to the editor regarding: ‘Hypocalcemia following denosumab in osteoporosis: Incidence and risk factors in a Saudi cohort’	14
Rheumatoid arthritis and osteogenesis imperfecta: is there a genetic causal association?	14
The effect of starting metformin on bone mineral density among women with type 2 diabetes in the Study of Women’s Health Across the Nation (SWAN)	14
The association between proton pump inhibitors and hyperparathyroidism: a potential mechanism for increased fracture—results of a large observational cohort study	14
Health-related quality of life in osteoporosis: a systematic review of measurement properties of the QUALEFFO-41	14
Prevalence of osteoporosis in older male veterans receiving hip-containing computed tomography scans: opportunistic use of biomechanical computed tomography analysis (BCT)	14
Birth weight and birth length affect future fracture risk differently in men and women	14
Risk of hypocalcaemia after denosumab administration	14
Romosozumab does not improve volumetric bone mineral density at distal radius but is associated with early changes in bone strength: a prospective study	14
Perioperative denosumab exposure and risk of revision after total hip and knee arthroplasty in osteoarthritis: a registry-based data linkage study	14
Proposed diagnostic criteria for the diagnosis of hypophosphatasia in children and adolescents: results from the HPP International Working Group	14
Regional data, global lessons: what the Asia–Pacific osteoporosis audit teaches the world	14
Denosumab therapy is associated with a reduced risk of clinically diagnosed rotator cuff tears: a multi-institutional real-world cohort study	14

The high-risk hip fracture patient and the palliative care consult	14
Biochemical and clinical manifestations in adults with hypophosphatasia: a national cross-sectional study	14
Prolonged hypercalcemia induced by teriparatide: a case report and literature review	13
The relationship between osteoporosis treatment history and receipt of a second zoledronic acid dose	13
Trends in serum phosphate, calcium, and parathyroid hormone levels according to renal function following denosumab	13
No overshoot of bone turnover after withdrawal of denosumab treatment of adults with Langerhans cell histiocytosis: a prospective clinical trial	13
Focal dermal hypoplasia: a probable underrecognized low bone mass disorder secondary to aberrant Wnt signaling	13
Author response to: OSIN-D-24–00381, artificial intelligence insights into osteoporosis	13
The Capture the Fracture® Partnership: an overview of a global initiative to increase the secondary fracture prevention care for patient benefit	13
Denosumab-associated symptomatic hypophosphatemia in normal kidney function: two case reports	13
Osteoporosis related to WNT1 variants: a not infrequent cause of osteoporosis	13
Discontinuation of denosumab in men with prostate cancer	13
Update on the role of bone turnover markers in the diagnosis and management of osteoporosis: a consensus paper from The European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthrit	13
Osteoporosis in older patients with idiopathic normal pressure hydrocephalus	13
Mental disorders and osteoporosis treatment in patients with hip fracture—a Danish population-based cohort study	13
Performance of FRAX in older adults with frailty: the Framingham Heart Study	13
The Geriatrics at Risk Score (GeRi-Score) for mortality prediction in geriatric patients with proximal femur fracture – a development and validation study from the Registry for Geriatric Trauma (ATR-D	13
Temporal trend of pediatric fracture epidemiology in Thailand: a nationwide study 2018–2024	13
Real-world rebound pattern of serum collagen type I C-telopeptide after denosumab discontinuation and zoledronate rescue in postmenopausal osteoporosis and cancer treatment-induced bone loss	12
Fracture rate increases after immune checkpoint inhibitor treatment: a potential new immune related adverse event	12
Exploratory use of romosozumab for osteoporosis in a patient with Hajdu–Cheney syndrome: a case report	12
Biomechanical heterogeneity of Tai Chi styles may influence bone mineral density responses	12
Bone density and fracture risk factors in ankylosing spondylitis: a meta-analysis	12
Trabecular bone mineral density as measured by thoracic vertebrae predicts incident hip and vertebral fractures: the multi-ethnic study of atherosclerosis	12
Reconsidering fracture risk reduction in Parkinson’s disease: limitations of claims-based inference	12
An invited rebuttal letter. Author response to: OSIN-D-25-02044: Critical considerations on the article by Bobelyak et al. (2025) “Bone mineral density assessment using radiofrequency echographic mult	12
Effect of osteoporosis medications on vascular and valvular calcification: a systematic review and meta-analysis	12
Opportunistic assessment of osteoporosis using hip and pelvic X-rays with OsteoSight™: validation of an AI-based tool in a US population	12
Psychotropic medication use and bone fracture risk among patients with multiple sclerosis: a real-world study	12
Preventing rebound fractures: the unresolved dental dilemma in denosumab discontinuation	12
B vitamins and bone health: a meta-analysis with trial sequential analysis of randomized controlled trials	12
Patients’ preferences for fracture risk communication: the Risk Communication in Osteoporosis (RICO) study	11
Interaction between diabetes and osteoporosis: imbalance between inflammation and bone remodeling	11
Biconcave vertebral fractures as a possible distinctive feature of indolent systemic mastocytosis compared with primary osteoporosis	11
Incidence of hip fractures in Mexico 2006–2019: increasing numbers but decreasing rates	11
Correction to: Melatonin at pharmacological concentrations suppresses osteoclastogenesis via the attenuation of intracellular ROS	11
Impact of switching from bisphosphonates to denosumab, teriparatide, or romosozumab in patients with postmenopausal osteoporosis: a case–control study	11
Chronic kidney disease and sarcopenia	11
CT image-based biomarkers for opportunistic screening of osteoporotic fractures: a systematic review and meta-analysis	11
The diagnostic value of MRI-based vertebral bone quality score for osteoporosis or osteopenia in patients undergoing lumbar surgery: a meta-analysis	11
Effects of combined protein and exercise interventions on bone health in middle-aged and older adults — A systematic literature review and meta-analysis of randomized controlled trials	11
Reply to comments on “Effect of selective serotonin reuptake inhibitors on bone mineral density: a systematic review and meta-analysis”	10
Fracture risks in patients with arginine vasopressin deficiency: a nationwide matched cohort study	10
Patients with periprosthetic femoral fractures are older adults who are commonly diagnosed with osteoporosis	10
Letter to the Editor regarding “The association between GLP-1 receptor agonists and fractures: a nationwide Danish nested case–control study”	10
Vitamin B6 challenge as a tool for detecting ALPL mutations and diagnosing hypophosphatasia	10
Vertebral fracture severity assessment on anteroposterior radiographs with a new semi-quantitative technique	10
Secular trend of humeral fractures incidence rates in patients ≥ 50 years requiring hospitalization: a retrospective analysis of the public health system data in Brazil from 2004 to 2013	10
Correction: Risk of major osteoporotic fractures among ultra-orthodox Jews	10
An Orthopaedic Surgeon Led Osteoporosis (OSLO) Model of Care reduces early recurrent fracture rates and improves treatment compliance in patients treated for osteoporotic fractures	10
Establishing a Chinese older hip fracture registry for older patients: a Delphi study to define the focus and key variables for this registry	10
Efficacy of denosumab in the treatment of hypercalcemic renal dysfunction in sarcoidosis: a case report	10
Trends in screening and treatment of osteoporosis after periprosthetic fractures from 2010 to 2020	10
Revised Swedish FRAX models and the establishment of age-dependent intervention thresholds	10
Bridging the gap: enhancing osteoporosis management through AI-driven predictive models	10
Standardized 25(OH)D and fall risk: overcoming challenges and enhancing clinical applications	10
Treatment of glucocorticoid-induced osteoporosis with concurrent denosumab and romosozumab: a case report	10
Appropriate dosing of burosumab in tumor-induced osteomalacia	10
Response to: Letter comments on: Radiofrequency Echographic Multi Spectrometry (REMS) for the evaluation of bone health in systemic lupus erythematosus (SLE)	10
Efficacy and safety of candidate biosimilar CT-P41 versus reference denosumab: a double-blind, randomized, active-controlled, Phase 3 trial in postmenopausal women with osteoporosis	10
Efficacy of romosozumab followed by denosumab in glucocorticoid users; a randomized clinical trial	10
Cost-effectiveness intervention thresholds for romosozumab and teriparatide in the treatment of osteoporosis in the UK	10
Gender differences in osteoporosis	10
Commentary on the Broader Perspectives of Hip Fractures in Primary Aldosteronism: From Medical to Social	10
Systematic review and meta-analysis of preoperative predictors for early mortality following hip fracture surgery	9
The effect of hypersensitive C-reactive protein to albumin ratio on the risk of fragility fracture in the Chinese male population	9
Author response to: OSIN-D-25–00317, “Comment on: The effect of hypersensitive C-reactive protein to albumin ratio on the risk of fragility fracture in the Chinese male population”	9
Comment on: The association between GLP-1 receptor agonists and fractures: a nationwide Danish nested case–control study	9
Letter to the editor regarding “Real-world rebound pattern of serum collagen type I C-telopeptide after denosumab discontinuation and zoledronate rescue in postmenopausal osteoporosis and cancer treat	9
Comparative efficacy of different traditional Chinese exercises on bone mineral density in older adults: a systematic review and network meta-analysis	9
Pharmacist interventions in osteoporosis management: a systematic review	9
DXA-based bone strain index in normocalcemic primary hyperparathyroidism	9
On the development and application of country-specific FRAX models in Latin America	9
Addressing the global burden of vitamin D deficiency: insights, challenges, and the need for personalized supplementation	9
State sequence analysis for a deeper understanding of treatment adherence patterns in fragility fracture patients	9
Preserved bone mineral density in autosomal dominant SP7-related osteogenesis imperfecta: a case report of the p.Glu340Ala variant	9
A systematic review and meta-analysis of sequential treatment strategies for osteoporosis	9
Time trend analysis of osteoporosis prevalence among adults 50 years of age and older in the USA, 2005–2018	9
IOF position on scientists and societies operating in conflict zones	9
Longitudinal assessment of physical function in adults with X-linked hypophosphatemia following initiation of burosumab therapy	9
Protein intake and bone health: an umbrella review of systematic reviews for the evidence-based guideline of the German Nutrition Society	9
Cost-effectiveness of FRAX®-based intervention thresholds for management of osteoporosis in Indian women: a Markov microsimulation model analysis	9
Muscle mass, not fat mass, predicts vertebral fracture risk: Vietnam osteoporosis study	9
Impact of a national reimbursement policy on anti-osteoporosis medication prescription at discharge after hip-fracture surgery in Japan: an interrupted time-series analysis	9
Diagnostic performance of radiomics for predicting osteoporosis in adults: a systematic review and meta-analysis	9
Vertebral fractures identified on lateral DXA images by deep learning predict incident fractures in older women	8
The effectiveness and cost-effectiveness of clinical fracture-risk assessment tools in reducing future osteoporotic fractures among older adults: a structured scoping review	8
Prevalence and relative risk of fractures and osteoporosis in patients with ankylosing spondylitis: a systematic review and meta-analysis	8
Differences in femoral fracture localizations in men and women in Switzerland between 1998 and 2021—reversal of the secular trend?	8
Adjusting conventional FRAX estimates of fracture probability according to the number of prior fractures	8
Metabolic associated fatty liver disease and bone mineral density: a cross-sectional study of the National Health and Nutrition Examination Survey 2017–2018	8
Clinical utility of one-third radius BMD in a population-based prospective cohort of older adults: Insights from the São Paulo Aging & Health (SPAH) study	8
Evidence-based joint statement position of perioperative bone optimization in the arthroplasty candidate, from FEMECOT, AMMOM, ACOMM, SCCOT, SECOT, SEFRAOS, SEIOMM	8
Prevalence and risk factors of osteoporosis and fragility fractures in aging Hakka women in Taiwan	8
The rise and fall of raloxifene use for osteoporosis, 1999–2022	8